News Feed
October 13, 2016
AutoSense cocaine detection study highlighted in Geisel Insider e-Magazine
A Northeast Node sponsored project, “Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network,” also known as AutoSense, was recently highlighted by the Geisel Insider, Dartmouth Medical School’s e-magazine.
The study, which is being done in collaboration with colleagues Dr. Santosh Kumar (Memphis University, Mobile Sensor Data-to-Knowledge Center of Excellence), Dr. Emre Ertin (Ohio State University), Dr. Kenzie Preston (NIDA Intramural Research Program), and Dr. August Holtyn (Johns Hopkins University), will develop a wrist-worn sensor that can detect in-the-moment cocaine use via interbeat heart rate. You can learn more about the study’s specific aims here.
You can read the full article published in the Geisel Insider here.
September 6, 2016
Node awarded Phase 2 of New Hampshire Fentanyl HotSpot Study
In partnership with the National Drug Early Warning System (NDEWS), the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) has been awarded funds to complete the second phase of the Fentanyl Hot Spot Study conducted in New Hampshire earlier this summer.
August 12, 2016
Node Involved in National Research Study
The CTN Northeast Node, alongside its partners, is participating in a nation-wide study of electronic health records (EHR) available throughout the CTN.
June 9, 2016
Node participating in NDEWS ‘Hot Spot’ study of New Hampshire fentanyl use
The CTN Northeast Node is pleased to announce our participation in a National Drug Early Warning Systems (NDEWS) “Hot Spot” study. NDEWS is a NIDA-funded cooperative agreement with the University of Maryland’s Center for Substance Abuse Research (CESAR).
May 16, 2016
NE Node Introduces #FeatureWeek to Social Media Accounts
The Northeast Node of the Clinical Trials Network is pleased to introduce #FeatureWeek to its social media platforms, May 16-22, 2016.
Once a month, our Twitter and Facebook pages will focus on a particular topic to highlight the most up-to-date research, news, and trending articles. The goal is to highlight the advances in the field in that area, to bring more awareness to something our followers may have limited knowledge of, and to spark an online discussion.
In our first installment, we focus on cannabis use to coincide with Dr. Alan Budney’s Science Series talk on Thursday, May 19. All week we’ll be pushing out the latest research on cannabis, laws from across the country, interviews with various experts in the field, and the views from both sides of the legalization argument.
May 16, 2016
NH Governor’s Summit addresses state opioid epidemic
The NH Governor’s Summit on Substance Misuse: A Multidisciplinary Approach to Addressing the Opioid Crisis, was held on Tuesday, May 10, 2016, in Manchester, NH. The Radisson Hotel was at maximum capacity, as over 850 people attended the Governor’s first summit. Teams and programs from all over the state attended, alongside police officers, families of overdose victims, people in recovery, and politicians working to change the way misuse is governed in the state.
May 4, 2016
Northeast Node to co-host New England ATTC conference on adolescent substance use disorders, July 20
Mark your calendars for July 20, 2016, when the Northeast Node of the NIDA Clinical Trials Network and the New England Addiction Technology Transfer Center will be hosting the 2nd annual regional adolescent conference, “Improving Care of Adolescents with Substance Use Disorders: Effective Approaches to Assessing, Treating, and Engaging Teens.”
May 4, 2016
Lisa A. Marsch named Andrew G. Wallace Professor
Northeast Node Principal Investigator and Center for Technology and Behavioral Health Director Lisa A. Marsch, PhD, was recently appointed the Andrew G. Wallace Professorship at Geisel School of Medicine at Dartmouth. Dr. Marsch’s appointment is a reflection on her dedication to the fields of substance use disorder treatment, behavioral health, and technology. We couldn’t be more proud! Congratulations, Dr. Marsch!
January 20, 2016
CTN approves AutoSense protocol
The Northeast Node is pleased to announce the approval of CTN-0073-Ot (Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network). The project will build upon our team’s recent work in successfully detecting cocaine use in the natural field environment using heart rate measurements. The goal of this project is to investigate methods to detect cocaine use from heart rate data captured by smartwatches, so this approach can be deployed widely in the NIDA Clinical Trials Network (CTN).